Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcomes of patients with IgA nephropathy in the German CKD cohort.
Stamellou E, Nadal J, Hendry B, Mercer A, Seikrit C, Bechtel-Walz W, Schmid M, Moeller MJ, Schiffer M, Eckardt KU, Kramann R, Floege J; GCKD study investigators. Stamellou E, et al. Among authors: eckardt ku. Clin Kidney J. 2024 Jul 22;17(8):sfae230. doi: 10.1093/ckj/sfae230. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39149090 Free PMC article.
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463. N Engl J Med. 2015. PMID: 26630142 Free article. Clinical Trial.
Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, Kotsis F, Schultheiss UT, Meiselbach H, Wanner C, Eckardt KU, Kronenberg F; GCKD Investigators. Kollerits B, et al. Among authors: eckardt ku. BMC Cancer. 2024 Mar 7;24(1):320. doi: 10.1186/s12885-024-12053-8. BMC Cancer. 2024. PMID: 38454416 Free PMC article.
Correction: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, Kotsis F, Schultheiss UT, Meiselbach H, Wanner C, Eckardt KU, Kronenberg F; GCKD Investigators. Kollerits B, et al. Among authors: eckardt ku. BMC Cancer. 2024 Mar 19;24(1):348. doi: 10.1186/s12885-024-12128-6. BMC Cancer. 2024. PMID: 38504160 Free PMC article. No abstract available.
Associations of Urine and Plasma Metabolites With Kidney Failure and Death in a Chronic Kidney Disease Cohort.
Steinbrenner I, Schultheiss UT, Bächle H, Cheng Y, Behning C, Schmid M, Yeo WJ, Yu B, Grams ME, Schlosser P, Stockmann H, Gronwald W, Oefner PJ, Schaeffner E, Eckardt KU, Köttgen A, Sekula P; GCKD Investigators. Steinbrenner I, et al. Among authors: eckardt ku. Am J Kidney Dis. 2024 Oct;84(4):469-481. doi: 10.1053/j.ajkd.2024.03.028. Epub 2024 May 28. Am J Kidney Dis. 2024. PMID: 38815646
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.
Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M, Eckardt KU, Kramann R, Moeller MJ, Floege J; GCKD study investigators. Stamellou E, et al. Among authors: eckardt ku. Clin Kidney J. 2024 Apr 27;17(7):sfae131. doi: 10.1093/ckj/sfae131. eCollection 2024 Jul. Clin Kidney J. 2024. PMID: 38989280 Free PMC article.
The membrane transporter SLC25A48 enables transport of choline into human mitochondria.
Patil S, Borisov O, Scherer N, Wirth C, Schlosser P, Wuttke M, Ehret S, Hannibal L, Eckardt KU, Hunte C, Neubauer B, Köttgen A, Köttgen M. Patil S, et al. Among authors: eckardt ku. Kidney Int. 2024 Jul 29:S0085-2538(24)00526-X. doi: 10.1016/j.kint.2024.06.022. Online ahead of print. Kidney Int. 2024. PMID: 39084256 Free article.
Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study.
Gruber I, Kollerits B, Forer L, Di Maio S, Schachtl-Riess JF, Kheirkhah A, Schönherr S, Schultheiss UT, Köttgen A, Eckardt KU, Coassin S, Lamina C, Kronenberg F. Gruber I, et al. Among authors: eckardt ku. J Intern Med. 2024 Dec;296(6):510-526. doi: 10.1111/joim.20027. Epub 2024 Nov 8. J Intern Med. 2024. PMID: 39513193
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD; EuroCYST Consortium; WGIKD. Spithoven EM, et al. Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14. Kidney Int. 2014. PMID: 24827775 Free article.
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.
Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium. Matsushita K, et al. Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. doi: 10.1016/S2213-8587(17)30183-3. Epub 2017 Jul 14. Lancet Diabetes Endocrinol. 2017. PMID: 28716631 Free PMC article.
683 results